[C56] DiPeri - Comparison of Patients with Small Bowel Neuroendocrine Tumor Liver Metastaseswith and without Carcinoid Syndrome: A Single Institutional Analysis

Published in 2021 Listed under Poster

Download

[C57] Chauhan - HPG80 (circulating progastrin), a Novel Blood-based Biomarker for Detection of Poorly Differentiated Neuroendocrine Carcinoma and Well Differentiated

Published in 2021 Listed under Poster

Download

[C5] Li - Interim analysis results of surufatinib in US patients with neuroendocrine tumors (NETs)

Published in 2021 Listed under Poster

Download

[C6] Guo - Impact of Capecitabine and Temozolomide on the Primary Tumor in Pancreatic Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[C7] Halperin - The Safety and Efficacy of PEN-221 Somatostatin Analog (SSA)-DM1 Conjugate in Patients (Pts) with Advanced GI Mid-gut Neuroendocrine Tumor (NET): Phase 2 Results

Published in 2021 Listed under Poster

Download

[C8] Reidy-Lagunes - Lanreotide Autogel/Depot (LAN) in Patients with Advanced Bronchopulmonary (BP) Neuroendocrine Tumors (NETs): Results From the Phase 3 SPINET Study

Published in 2021 Listed under Poster

Download

[C9] Siddiqui - Real World Use of Lanreotide in Management of Neuroendocrine Tumours

Published in 2021 Listed under Poster

Download

[O1] Das - A Systematic Survey of Two Decades of Clinical Trials in Neuroendocrine Neoplasms (NENs)

Published in 2021 Listed under Poster

Download

[O2] Yen - The Feasibility and Acceptability of Health and Wellness Coaching for Neuroendocrine Tumor Patients and Their

Published in 2021 Listed under Poster

Download

[O3] Hallet - Patient-reported Cognitive and Psychological Screening in Neuroendocrine Tumors (NETs) - a Prospective Cohort

Published in 2021 Listed under Poster

Download

[O4] Kolarova - Neuroendocrine Tumor Treatments and Follow-up Disease Management - Comparative Perspective (U.S. and Canada

Published in 2021 Listed under Poster

Download

[O5] Hickman - Outcomes of Initial Treatment in Early Stage Neuroendocrine Carcinoma of the Uterine Cervix (NCUC)

Published in 2021 Listed under Poster

Download

[O6] Tsang - Evaluating the Association Between Family History and Overall Survival Among Patients with Gastrointestinal and Pancreatic Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[O7] Wachtel - Succinate Dehydrogenase Pathogenic Variants are Not Associated with Non-canonical Cancers

Published in 2021 Listed under Poster

Download

[O8] Anaka - Understanding Neuroendocrine Tumour Patient Preferences for Medical Management of Midgut NETs Using Discrete Choice Experiments: a DIRECT NETs Study

Published in 2021 Listed under Poster

Download

[P10] Rakshit - Covid-19 in Patients with Neuroendocrine Tumors (NETs): the Mayo Clinic Experience

Published in 2021 Listed under Poster

Download

[P11] Abdelrahman - The Epidemiology of Mixed Acinar Neuroendocrine Carcinoma of the Pancreas in the United States

Published in 2021 Listed under Poster

Download

[P12] Albor - MDT Experience in Argentina in Nets in Times of the Covid19 Pandemic

Published in 2021 Listed under Poster

Download

[P1] Wong - Predictors And Outcomes Of Minimally Invasive Surgery For Small Bowel Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[P2] Hallet - Incidence of Psychiatric Illness in Patients With Neuroendocrine Tumors - A Comparative Population-Based

Published in 2021 Listed under Poster

Download

[P3] Bateni - Incidence and Predictors of Second Cancers in Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[P4] Bateni - Secondary Primary Cancers and Survival among Neuroendocrine Tumor Patients

Published in 2021 Listed under Poster

Download

[P5] Zarate Rodriguez - Race is an Independent Predictor for Surgery Offer in Patients with Small Bowel Neuroendocrine Tumors But Not Pancreatic Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[P6] Zarate Rodriguez - Surgical Interventions in Patients with Pancreatic Neuroendocrine Tumors: a SEER-based Survival Analysis

Published in 2021 Listed under Poster

Download

[P7] Lee - Prevalence and Presentation of Cushing and Carcinoid Syndromes in Patients with Non-metastatic Primary Lung

Published in 2021 Listed under Poster

Download

[P8] Harsha Tella - Association Between Hospital Volume and Overall Survival of Pancreatic Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[P9] Mulvey - The Impact of Sociodemographic Factors on Overall Survival for Patients with Adrenocortical Carcinomas in California

Published in 2021 Listed under Poster

Download

[T1] El-Rayes - Safety, Pharmacodynamic, and Antitumor Activity of Tidutamab, an SSTR2 x CD3 Bispecific Antibody, in Subjects with Advanced Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[T2] Lagast - Dose Selection for Paltusotine, a Once Daily Oral Nonpeptide, Somatostatin Receptor 2 Ligand, for the Treatment of Patients with Carcinoid Syndrome (CS)

Published in 2021 Listed under Poster

Download

[T3] Singh - [177Lu]Lu-DOTA-TATE as First-line Therapy for Patients with Grade 2 and 3 Advanced Gastroenteropancreatic Neuroendocrine Tumors (GEP-NETs): the NETTER-2 Study

Published in 2021 Listed under Poster

Download

[T4] O'Dorisio - A Phase II Trial to Evaluate the Safety and Dosimetry of [177Lu]Lu-DOTA-TATE in Adolescent Patients with Somatostatin Receptor (SSTR)-positive Gastroenteropancreatic Neuroendocrine Tumors (GEP

Published in 2021 Listed under Poster

Download

[T5] Chauhan - ETCTN 10388: a Phase 1 Trial of Triapine and Lutetium 177 Dotatate in Well-differentiated Somatostatin Receptorpositive Gastroenteropancreatic Neuroendocrine Tumors

Published in 2021 Listed under Poster

Download

[T6] Chauhan - ETCTN 10450: a Phase 1 Trial of Peposertib and Lutetium Lu 177 Dotatate in Well-differentiated Somatostatin Receptor

Published in 2021 Listed under Poster

Download